Chapel Hill, NC7 Active Studies

Parkinsons Disease Clinical Trials in Chapel Hill, NC

Find 7 actively recruiting parkinsons disease clinical trials in Chapel Hill, NC. Connect with local research sites and explore new treatment options.

7
Active Trials
4
Sponsors
528
Enrolling

Recruiting Parkinsons Disease Studies in Chapel Hill

About Parkinsons Disease Clinical Trials in Chapel Hill

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 7 parkinsons disease clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 528 participants. Research is being sponsored by Verastem, Inc., University of North Carolina, Chapel Hill, UNC Lineberger Comprehensive Cancer Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Chapel Hill — FAQ

Are there parkinsons disease clinical trials in Chapel Hill?

Yes, there are 7 parkinsons disease clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 7 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 17, 2026 from ClinicalTrials.gov